Organ Preservation Solutions Market
- 2026 年市場規模
- USD 450 Mn
- 2033 年預估規模
- USD 996 Mn
- 年複合成長率 CAGR
- 12%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Organ Preservation Solutions Market, By Solution Type (Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solutions, Others), By Technique Type (Hypothermic Perfusion Preservation, Static Cold Storage, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
Organ preservation involves removal of organs from the bodies, which are then stored for transplantation. Organ preservation systems are exclusively prepared and maintained according to the biological environment (temperature and oxygen) needed to store particular organs. Different body organs require specific and suitable storage conditions to maintain their anatomical and physiological processes. Important parameters in organ preservation include delivering of high quality organs to the donors, matching the patient and organ suitability, and restart of life of the organs and sustaining functions after the transplantation. Organ transplantation process starts with removing the needed organ from the donor body, then the organ is stored and transported.
Restraints of the Global Organ Preservation Solutions Market
Major factors hampering the growth of the organ preservation solutions market during the forecast period constitutes of advent of stem cells, and high costs.
Key features of the study
• This report provides in-depth analysis of the global organ preservation solutions market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2026 - 2033), considering 2025, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global organ preservation solutions market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Dr. Franz Köhler Chemie GmbH, BioLife Solutions, XVIVO Perfusion AB, Bristol-Myers Squibb, Inc., and ToleroTech, Inc., Lifeline Scientific, Preservation Solutions Inc., Claris Injectables Limited, 21st Century Medicine, Paragonix Technologies Inc., BioTime, Inc. CryoLife, Inc., and Dr. Franz Köhler Chemie GmbH.
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global organ preservation solutions market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Market Segmentation
• By Solution Type Insights (Revenue, USD Mn, 2021 - 2033)
o Viaspan
o Custodiol HTK
o Renograf
o Hypothermosol
o Perfadex
o Lifor
o HBS Solution
o siRNA Transplant Solutions
o Others
• By Techniques Type Insights (Revenue, USD Mn, 2021 - 2033)
o Hypothermic Perfusion Preservation
o Static Cold Storage
o Others
• By Region Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players in the Organ Preservation Solutions Market
o Teva Pharmaceutical Industries Ltd.
o Franz Köhler Chemie GmbH
o BioLife Solutions
o XVIVO Perfusion AB
o Bristol-Myers Squibb, Inc.
o ToleroTech, Inc.
o Lifeline Scientific
o Preservation Solutions Inc.
o Claris Injectables Limited
o 21st Century Medicine
o Paragonix Technologies Inc.
o BioTime, Inc.
o CryoLife, Inc.
目錄 Table of Contents
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Solution Type
Market Snippet, By Technique Type
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Key Developments
o Regulatory Scenario
o PEST Analysis
4. Global Organ Preservation Solutions Market, By Solution Type, 2021 – 2033 (US$ Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Viaspan
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
Segment Trends
o Custodiol HTK
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
Segment Trends
o Renograf
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
Segment Trends
o Hypothermosol
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
Segment Trends
o Perfadex
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
Segment Trends
o Lifor
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
Segment Trends
o HBS Solution
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
Segment Trends
o siRNA
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
Segment Trends
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
Segment Trends
5. Global Organ Preservation Solutions Market, By Technique Type, 2021 – 2033 (US$ Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Hypothermic Perfusion Preservation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
o Static Cold Storage
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
6. Global Organ Preservation Solutions Market, By Regions, 2021 – 2033 (US$ Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
o U.S.
o Canada
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
o North Africa
o Central Africa
o South Africa
7. Competitive Landscape
o Company Profiles
Teva Pharmaceutical Industries Ltd.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Franz Köhler Chemie GmbH
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
BioLife Solutions
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
XVIVO Perfusion AB
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Bristol-Myers Squibb, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
ToleroTech, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Lifeline Scientific
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Preservation Solutions Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Claris Injectables Limited
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
21st Century Medicine
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Paragonix Technologies Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
BioTime, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
CryoLife, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
8. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療器材）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們